The designer who introduced the iPhone Air at Apple's September event left the company, reports Bloomberg. Abidur Chowdhury ...

MetaVia ( ($MTVA) ) has shared an update. On November 6, 2025, MetaVia Inc. released an updated corporate presentation detailing its ongoing ...

HOUSTON, TX / ACCESS Newswire / November 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a ...

Mosanada is a leading specialised facility management services provider offering comprehensive solutions to clients in Qatar• Strong financial performance ...

Invivyd, Inc. advances VYD2311 as a Covid-19 vaccine alternative. Learn about upcoming trials and market opportunities. Click ...

Significant improvements observed in secondary endpoints, including reductions in liver fat, inflammation and biomarkers of fibrosis GAITHERSBURG, Md., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc ...

Pre-NDA meeting with FDA to discuss brilaroxazine’s path to approval for schizophrenia planned in Q4 2025 – – Potential NDA submission for ...

R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advan ...

Navios Maritime Partners L.P. Common Units ( NMM) Q3 2025 Earnings Call November 18, 2025 8:30 AM EST ...

Net Loan-To-Value (LTV) -- 34.5% with a target net LTV range of 20%-25% stated by management. Available Liquidity -- $412 million reported as of quarter-end. Contracted Revenue Backlog -- $3.7 billion ...

Zymeworks stock rose 57% after Phase 3 trial showed Ziihera improved survival in HER2-positive gastroesophageal cancer ...

Initiated registrational Phase 2b SAFEGUARD trial of SAB-142 in new-onset, Stage 3 autoimmune T1D patientsMultiple SAFEGUARD ...